Have a personal or library account? Click to login
Exploring patient and clinician perspectives on the benefits and risks of emerging therapies for the treatment of haemophilia: a qualitative study Cover

Exploring patient and clinician perspectives on the benefits and risks of emerging therapies for the treatment of haemophilia: a qualitative study

Open Access
|Apr 2024

References

  1. Spoors J, McEntee J, Horsley W, Cairns J, Payne K, Wright S. PO178. Enhanced horizon scanning for the haemophilia pharmaceutical pipeline 2022-2026. Haemophilia 2023; 29(S1): 122. doi: 10.1111/hae.14715.
  2. European Medicines Agency. Advanced therapy medicinal products: Overview [Internet]. 2016. Available from: https://www.ema.europa.eu/en/human-regulatory/overview/advanced-therapy-medicinal-products-overview (accessed July 2020).
  3. Spoors J, Cairns J, Miners A. Discrete choice experiments: An overview of experience to date in haemophilia. J Haem Pract 2022; 9(1): 50-63. doi: 10.2478/jhp-2022-0006.
  4. Spoors J, Miners A, Cairns J, et al. Payer and implementation challenges with advanced therapy medicinal products (ATMPs). BioDrugs 2021; 35(1): 1-5. doi: 10.1007/s40259-020-00457-4.
  5. Fletcher S, Jenner K, Pembroke L, Holland M, Khair K. The experiences of people with haemophilia and their families of gene therapy in a clinical trial setting: regaining control, the Exigency study. Orphanet J Rare Dis 2022;17(1): 155. doi: 10.1186/s13023-022-02256-2.
  6. Woollard L, Gorman R, Rosenfelt DJ. Addressing patient education priorities in the era of gene therapy for haemophilia: Towards evidence-informed shared decision-making. Haemophilia 2021; 27(2): e302-e304. doi: 10.1111/hae.14214.
  7. van Overbeeke E, Hauber B, Michelsen S, et al. Patient preferences for gene therapy in haemophilia: Results from the PAVING threshold technique survey. Haemophilia 2021; 27(6): 957-966. doi: 10.1111/hae.14401.
  8. Limjoco J, Calatroni A, Aristizabal P, Thornburg CD. Gene therapy preferences and informed decision-making: Results from a National Hemophilia Foundation Community Voices in research survey. Haemophilia 2023; 29(1): 51-60. doi: 10.1111/hae.14706.
  9. Langstaff B. Infected Blood Inquiry [Internet]. 2021. Available from: https://www.infectedbloodinquiry.org.uk/ (accessed June 2023).
  10. Terris-Prestholt F, Quaife M, Vickerman P. Parameterising user uptake in economic evaluations: The role of discrete choice experiments. Health Econ 2016; 25: 116-23. doi: 10.1002/hec.3297.
  11. Horne R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999; 47(6):555-67. doi: 10.1016/s0022-3999(99)00057-4.
  12. Elwyn G, Frosch D, Thomson R, et al. Shared decision making: A model for clinical practice. J Gen Intern Med 2012; 27(10): 1361-1367. doi: 10.1007/s11606-012-2077-6.
  13. Karazivan P, Dumez V, Flora L, et al. The patient-as-partner approach in health care: A conceptual framework for a necessary transition. Acad Med 2015; 90(4): 437-41. doi: 10.1097/ACM.0000000000000603.
  14. Hermans C, Noone D, Benson G, et al. Hemophilia treatment in 2021: Choosing the “optimal” treatment using an integrative, patient-oriented approach to shared decision-making between patients and clinicians. Blood Rev 2022; 52: 100890. doi: 10.1016/j.blre.2021.100890.
  15. Quill TE, Brody H. Physician recommendations and patient autonomy: Finding a balance between physician power and patient choice. Ann Intern Med 1996; 125(9): 763-9. doi: 10.7326/0003-4819-125-9-199611010-00010.
  16. Fischhoff B, Brewer NT, Downs J. Communicating Risks and Benefits: An Evidence-Based User’s Guide. US Food and Drug Administration, 2011. Available from: https://www.fda.gov/media/81597/download.
  17. Nutbeam D. The evolving concept of health literacy. Soc Sci Med 2008; 67(12): 2072-8. doi: 10.1016/j.socscimed.2008.09.050.
  18. DeWalt DA, Berkman ND, Sheridan S, Lohr KN, Pignone MP. Literacy and health outcomes: A systematic review of the literature. J Gen Intern Med 2004; 19(12): 1228-39. doi: 10.1111/j.1525-1497.2004.40153.x.
  19. Visscher BB, Steunenberg B, Heijmans M, et al. Evidence on the effectiveness of health literacy interventions in the EU: A systematic review. BMC Public Health 2018;18(1): 1414. doi: 10.1186/s12889-018-6331-7.
  20. Slovic P, Peters E, Finucane ML, MacGregor DG. Affect, risk, and decision making. Health Psychol 2005; 24(4S): S35-40. doi: 10.1037/0278-6133.24.4.S35.
  21. Lerner JS, Keltner D. Fear, anger, and risk. J Pers Soc Psychol 2001; 81(1): 146-59. doi: 10.1037//0022-3514.81.1.146.
  22. Wardman JK. Toward a critical discourse on affect and risk perception. J Risk Res 2006; 9(2): 109-124. doi: 10.1080/13669870500454773.
  23. Frosch DL, Kaplan RM. Shared decision making in clinical medicine: Past research and future directions. Am J Prev Med 1999; 17(4): 285-94. doi: 10.1016/s0749-3797(99)00097-5.
  24. Street RL, Gordon HS, Ward MM, Krupat E, Kravitz RL. Patient participation in medical consultations: Why some patients are more involved than others. Med Care 2005; 43(10): 960-9. doi: 10.1097/01.mlr.0000178172.40344.70.
  25. Sleath B, Tulsky JA, Peck BM, Thorpe J. Provider-patient communication about antidepressants among veterans with mental health conditions. Am J Geriatr Pharmacother 2007; 5(1): 9-17. doi: 10.1016/j.amjopharm.2007.03.002.
  26. Fried TR, Tinetti ME, Towle V, O’Leary JR, Iannone L. Effects of benefits and harms on older persons’ willingness to take medication for primary cardiovascular prevention. Arch Intern Med 2011;171(10): 923-8. doi: 10.1001/archinternmed.2011.32.
  27. Lumivero. NVIVO (Version 12) [Internet]. 2018. Available from: https://lumivero.com/products/nvivo/ (accessed July 2023).
  28. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006; 3(2): 77-101. doi: 10.1191/1478088706qp063oa.
  29. Moxey A, O’Connell D, McGettigan P, Henry D. Describing treatment effects to patients. J Gen Intern Med 2003; 18(11): 948-59. doi: 10.1046/j.1525-1497.2003.20928.x.
  30. Gigerenzer G. Why does framing influence judgment? J Gen Intern Med 2003; 18(11): 860-961. doi: 10.1046/j.1525-1497.2003.30901.x.
  31. Edwards A, Elwyn G, Covey J, Matthews E, Pill R. Presenting risk information—a review of the effects of “framing” and other manipulations on patient outcomes. J Health Commun 2001; 6(1): 61-82. doi: 10.1080/10810730150501413.
  32. Feldman-Stewart D, Brennenstuhl S, McIssac K, et al. A systematic review of information in decision aids. Health Expect 2007; 10(1): 46-61. doi: 10.1111/j.1369-7625.2006.00420.x.
  33. Ankolekar A, Dekker A, Fijten R, Berlanga A. The benefits and challenges of using patient decision aids to support shared decision making in health care. JCO Clin Cancer Inform 2018; (2): 1-10. doi: 10.1200/CCI.18.00013.
  34. Trenaman L, Bryan S, Bansback N. The cost-effectiveness of patient decision aids: A systematic review. Healthc (Amst) 2014; 2(4): 251-7. doi: 10.1016/j.hjdsi.2014.09.002.
  35. Fletcher S, Jenner K, Khair K. Shared decision-making for gene therapy in haemophilia care. J Haem Pract 2023; 10(1): 62-7. doi: 10.2478/jhp-2023-0009.
  36. Hermans C, Gruel Y, Frenzel L, Krumb E. How to translate and implement the current science of gene therapy into haemophilia care? Ther Adv Hematol 2023; 14: 20406207221145627. doi: 10.1177/20406207221145627.
  37. Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica 1979; 47(2): 263-292. doi: 10.2307/1914185.
  38. Barberis NC. Thirty years of prospect theory in economics: A review and assessment. The Journal of Economic Perspectives 2013; 27(1): 173-195. http://www.jstor.org/stable/41825467.
  39. De Martino I, D’Apolito R, McLawhorn AS, Fehring KA, Sculco PK, Gasparini G. Social media for patients: benefits and drawbacks. Curr Rev Musculoskelet Med 2017; 10(1): 141-145. doi: 10.1007/s12178-017-9394-7.
  40. Benetoli A, Chen TF, Aslani P. How patients’ use of social media impacts their interactions with healthcare professionals. Patient Educ Couns 2018; 101(3): 439-444. doi: 10.1016/j.pec.2017.08.015.
  41. Graham AL, Cobb CO, Cobb NK. The internet, social media, and health decision-making. In: Diefenbach MA, Miller-Halegoua S, Bowen DJ (Eds.). Handbook of Health Decision Science. Springer Science + Business Media; 2016. 335-355.
  42. Limjoco J, Thornburg CD. Development of a haemophilia A gene therapy shared decision-making tool for clinicians. Haemophilia 2023; 29(5): 1184-1190. doi: 10.1111/hae.14822.
  43. Knapp M, Wong G. Economics and mental health: the current scenario. World Psychiatry 2020; 19(1): 3-14. doi: 10.1002/wps.20692.
  44. Hindmarch T, Hotopf M, Owen GS. Depression and decision-making capacity for treatment or research: A systematic review. BMC Med Ethics 2013; 14(1): 54. doi: 10.1186/1472-6939-14-54.
  45. Duncan E, Best C, Hagen S. Shared decision making interventions for people with mental health conditions. Cochrane Database Syst Rev 2010; 2010(1): CD007297. doi: 10.1002/14651858.CD007297.pub2.
  46. Timmermans S. The engaged patient: the relevance of patient-physician communication for twenty-first-century health. J Health Soc Behav 2020; 61(3): 259-273. doi: 10.1177/0022146520943514.
  47. UKHCDO. UKHCDO Annual Report 2022 & Bleeding Disorder Statistics for the Financial Year 2021/22. A Report from the UKHCDO and NHD. Manchester: UKHCDO; 2022. Available from https://www.ukhcdo.org/wp-content/uploads/2022/12/UKHCDO-Annual-Report-2022-2021-22-Data.pdf.
  48. Baillie L. Exchanging focus groups for individual interviews during qualitative data collection: A discussion. Nurse Res 2019. doi: 10.7748/nr.2019.e1633.
  49. SPS. SPS Horizon Scanning Service [Internet]. Available from: https://www.sps.nhs.uk/articles/sps-horizon-scanning-service/ (accessed January 2022).
Language: English
Page range: 21 - 37
Published on: Apr 8, 2024
Published by: Haemnet Ltd
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2024 John Spoors, Katherine Payne, Stuart Wright, Will Horsley, Sadie Bell, John Cairns, published by Haemnet Ltd
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.